Oxandroxyl 10 - Kalpa Pharmaceuticals

First developed in 1962 by G.D. Searle & Co., Oxandrolone was marketed as Anavar and intended as a safe, effective treatment for catabolic medical conditions. It became a mainstay in managing weight loss in cancer patients, burn victims, and children with hormone deficiencies. Despite wide approval, concern over anabolic abuse led to its discontinuation in 1989. The compound resurfaced as Oxandrin in 1995, manufactured by Bio-Technology General Corp. and limited to approved medical uses such as HIV wasting and Turner syndrome, protected under FDA orphan drug designation.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxandroxyl 10 by Kalpa Pharmaceuticals, consult with your doctor or healthcare professional.